Novartis to Cut 1,960 Jobs, Take Charge on Diovan, Tekturna

Novartis to Cut 1,960 Jobs, Take Charge on Diovan, Tekturna

Jim R. Bounds/Bloomberg

Syringes make their way though a machine as testing is conducted on new manufacturing equipment at the Novartis Vaccines and Diagnostics Flu Cell Culture Manufacturing Facility in Holly Springs, North Carolina, U.S.